SPG11 Mutations Associated With a Complex Phenotype Resembling Dopa‐Responsive Dystonia. Issue 2 (28th April 2015)

• Record Type: Journal Article
• Authors: Wijemanne, Subhashie; Shulman, Joshua M.; Jimenez‐Shahed, Joohi; Curry, Daniel; Jankovic, Joseph
• Is Part Of: Movement disorders clinical practice. Volume 2:Issue 2(2015)
• Page Start: 149
• Page End: 154
• Publication Date: 2015-04-28
• Subjects: SPG11 -- hereditary spastic paraplegia -- thin corpus callosum -- dopa‐responsive dystonia -- parkinsonism; Movement Disorders; Movement disorders -- Periodicals; Movement disorders; Periodicals; Periodicals; 616
• DOI: 10.1002/mdc3.12144
• Languages: English
• ISSNs: 2330-1619

Abstract

Abstract: Background: The aim of this study was to describe a case of hereditary spastic paraplegia (HSP) resulting from SPG11 mutations, presenting with a complex phenotype of dopa‐responsive dystonia (DRD), diagnosed using whole exome sequencing (WES). HSP resulting from SPG11 typically presents with spasticity, cognitive impairment, and radiological evidence of thin corpus callosum. Initial presentation with DRD has not been previously reported on. Methods: This 11‐year‐old boy with delay in fine motor skills, presented at 8 years of age with progressive, generalized dystonia with diurnal variation, bradykinesia, and stiff gait. There was marked improvement in dystonia with levodopa, but he soon developed wearing‐off phenomenon and l ‐dopa‐induced dyskinesia. Family history was unremarkable. Results: Brain MRI showed thinning of the anterior corpus callosum with periventricular white matter changes. 123 I‐ioflupane single‐photon emission coupled tomography showed bilateral severe presynaptic dopamine deficiency. WES identified transheterozygous allelic variants in the SPG11 on chromosome 15, including a truncating STOP mutation (p.E1630X) and a second heterozygous coding variant (p.L2300R). Dystonia improved with globus pallidus internus (GPi) DBS surgery. Conclusions: HSP resulting from SPG11 should be considered in the differential diagnosis of a patient presenting with DRD, parkinsonism, and spasticity. This case expands the HSP genotype and phenotype. GPi DBS may be a therapeutic option in selected patients.